Recent advances in astragalus membranaceus anti-diabetic research: Pharmacological effects of its phytochemical constituents

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Agyemang, Kojo ^a,b   Han, Lifeng ^a   Liu, Erwei ^a   Zhang, Yi ^a   Wang, Tao ^a   Gao, Xiumei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b University of Ghana   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO ACID DERIVATIVE; ANTIDIABETIC AGENT; ASTRAGALUS MEMBRANACEUS EXTRACT; CASPASE 3; CYCLOOXYGENASE 2; ESSENTIAL OIL; FLAVONOID; GAMMA INTERFERON; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; SAPONIN DERIVATIVE; STEROL DERIVATIVE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTRAGALUS MEMBRANACEUS; CELL MATURATION; CHINESE MEDICINE; ENDOPLASMIC RETICULUM STRESS; ENERGY BALANCE; ETHNOPHARMACOLOGY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LYMPHOCYTE DIFFERENTIATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE;

EID: 84890067833     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/654643     Document Type: Review

References (94)

1. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
2. Einhorn D., Advances in diabetes for the millennium: insulin treatment and glucose monitoring CME. MedGenMed Medscape General Medicine 2004 6 supplement 3 8 2-s2.0-22044451377
3. Rendell M., Advances in diabetes for the millennium: drug therapy of type 2 diabetes. Medscape General Medicine 2004 6 supplement 3 9 2-s2.0-33746727682
4. Lambert P., Bingley P. J., What is type 1 diabetes? Medicine 2002 30 1 1 5 2-s2.0-3042713231
5. Berman B. M., Swyers J. P., Kaczmarczyk J., Complementary and alternative medicine: herbal therapies for diabetes. Journal of the Association for Academic Minority Physicians 1999 10 1 10 14 2-s2.0-0033287310
6. Jia W., Gao W., Xiao P., Antidiabetic drugs of plant origin used in China: compositions, pharmacology, and hypoglycemic mechanisms. Zhongguo Zhongyao Zazhi 2003 28 2 108 113 2-s2.0-2942642382 (Pubitemid 41250664)
7. Wei D. X., Yu N. Z., Ya O. Z., Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus. Evidence-Based Complementary and Alternative Medicine 2011 2011 13 2-s2.0-79955117591 10.1155/2011/726723 726723
8. Li W. L., Zheng H. C., Bukuru J., De Kimpe N., Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004 92 1 1 21 2-s2.0-1942424088 10.1016/j.jep.2003.12.031 (Pubitemid 38510258)
9. Zang S. F., Ning L., Ni H. X., Zhang Q. L., Chen Z. J., The effect of Astragalus on PPAR- γ mRNA expression in macrophage with Type2 Diabetic Mellitus. Chinese Archives of Traditional Chinese Medicine 2006 29 8 1853
10. Liang X. C., Cui L. Y., Guo S. S., Zhang K. J., Hao W. X., Jia L., Zhang H., Sun R. Y., Li B. H., Du H., Clinical study of Jinmaitong composita on diabetic peripheral neuropathy. Chinese Journal of Integrative Medicine 2001 7 2 103 106
11. Seely D., Mills E., Rachlis B., Patients with diabetes using alternative medicine. Contemporary Endocrinology (Evidence-Based Endocrinology) 2006 4 323 342
12. Keji C., Understanding and treatment of diabetes mellitus by traditional Chinese medicine. American Journal of Chinese Medicine 1981 9 1 93 94 2-s2.0-0019775157 (Pubitemid 12190237)
13. Sang Z., Zhou L., Fan X., McCrimmon R. J., Radixz astragali (Huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes. American Journal of Chinese Medicine 2010 38 6 1027 1038 2-s2.0-78149445050 10.1142/S0192415X10008445
14. Zang S. F., Ning L., Ni H. X., Zhang Q. L., Chen Z. J., The effect of Astragalus on PPAR- γ mRNA expression in macrophage with type2 diabetic mellitus. Chinese Archives of Traditional Chinese Medicine 2011 29 8 1853 1855
15. Chao M., Zou D., Zhang Y., Chen Y., Wang M., Wu H., Ning G., Wang W., Improving insulin resistance with traditional Chinese medicine in type 2 diabetic patients. Endocrine 2009 36 2 268 274 2-s2.0-73349095011
16. Zhang D. Q., Zhang J. J., Wang J. X., Hu S. M., Li W., Ou L. N., Chen S., Gao X., Effects of Qilan Tangzhining capsule on glucose and lipid metabolism in rats with diabetes mellitus and hyperlipemia. Zhongguo Zhongyao Zazhi 2005 30 10 773 777 2-s2.0-33745096028 (Pubitemid 44367094)
17. Qin Q. J., Niu J. Y., Wang Z. X., Xu W. J., Qiao Z. D., Gu Y., Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)- B Pathways in Advanced Glycation End Product-Stimulated Macrophages. International Journal of Molecular Sciences 2012 13 7 8379 8387
18. Shen P., Liu M. H., Ng T. Y., Chan Y. H., Yong E. L., Differential effects of isoflavones, from Astragalus membranaceus and Pueraria Thomsonii, on the activation of PPAR α PPAR γ and adipocyte differentiation in vitro. Journal of Nutrition 2006 136 4 899 905 2-s2.0-33645512781
19. WHO, Radix Astragali 1999 1 Geneva, Switzerland WHO Monographs on Selected Medicinal Plants
20. Thorne Research Incoporated, Astragulus membranaceus monograph alternative medicine review. Thorne Research Incoporated 2003 8 1 72 77
21. Liu X., Wang M., Wu H., Zhao X., Li H., Isolation of astragalan and its immunological activities. Tianran Chanwu Yanjiu Yu Kaifa 1994 6 23 31
22. Fang S. D., Chen Y., Ye C. Q., Zhai S. K., Shen M. L., Studies of the active principles of Astragalus Mongholicus Bunge I. isolation, characterization and biological effect of its polysaccharides. Chinese Journal of Organic Chemistry 1982 1 26 31
23. Zou Y. Y., Gu X. Q., Chen Q., Investigation of the polyphase liposomal bipolysaccharides-Part 1. Selection and analysis of the effective ingredients in the two polysaccharides. Journal of Shenyang Pharmaceutical University 1987 4 3 170 174
24. Tomoda M., Shimizu N., Ohara N., Gonda R., Ishii S., Otsuki H., A reticuloendothelial system-activating glycan from the roots of Astragalus membranaceus. Phytochemistry 1991 31 1 63 66 2-s2.0-44949278276
25. Mu L. X., Zhu L., Zhao A. H., Zhou M. M., Jia W., Study on extraction and purification of polysaccharides from Astragalus membranaceus. Zhong Yao Cai 2009 32 11 1741 1745 2-s2.0-79952118354
26. Wang S. C., Shan J. J., Wang Z. T., Hu Z. B., Isolation and structural analysis of an acidic polysaccharide from Astragalus membranaceus (Fisch.) Bunge. Journal of Integrative Plant Biology 2006 48 11 1379 1384 2-s2.0-33845521919 10.1111/j.1744-7909.2006.00325.x (Pubitemid 44920902)
27. Jing L., Zhen Z. Z., Biao C. H., Review of Astragali radix. Chinese Herbal Medicines 2011 3 2 90 105
28. Kajimura K., Takagi Y., Ueba N., Yamasaki K., Sakagami Y., Yokoyama H., Yoneda K., Protective effect of Astragali Radix by intraperitoneal injection against Japanese encephalitis virus infection in mice. Biological and Pharmaceutical Bulletin 1996 19 6 855 859 2-s2.0-0029987694 (Pubitemid 26243239)
29. Bombardelli E., Pozzi R., Polysaccharides with immunomodulating properties from Astragalus membranaceus and pharmaceutical compositions containing them. 1994, http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/ 2035948/summary.html
30. Kitagawa I., Wang H. K., Saito M., Saponin and Sapogenol. XXXV. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (2). Astragalosides I, II, and IV, acetylastragaloside I and isoastragalosides I and II. Chemical and Pharmaceutical Bulletin 1983 31 2 698 708 2-s2.0-0020628166 (Pubitemid 13080828)
31. Kitagawa I., Wang H. K., Saito M., Yoshikawa M., Saponin and Sapogenol. XXXVI. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (3). Astragalosides III, V, and VI. Chemical and Pharmaceutical Bulletin 1983 31 2 709 715 2-s2.0-0020622373 (Pubitemid 13080829)
32. Kitagawa I., Wang H. K., Yoshikawa M., Saponin and Sapogenol. XXXVII. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (4) Astragalosides VII and VIII. Chemical and Pharmaceutical Bulletin 1983 31 2 716 722 2-s2.0-0020631501 (Pubitemid 13080830)
33. Kim J. S., Yean M., Lee E., Jung H. S., Lee J. Y., Kim Y. J., Kang S. S., Two new cycloartane saponins from the roots of Astragalus membranaceus. Chemical and Pharmaceutical Bulletin 2008 56 1 105 108 2-s2.0-38049153262 10.1248/cpb.56.105
34. Chu C., Cai H., Ren M., Liu E.-H., Li B., Qi L., Li P., Characterization of novel astragaloside malonates from Radix Astragali by HPLC with ESI quadrupole TOF MS. Journal of Separation Science 2010 33 4-5 570 581 2-s2.0-77749310126 10.1002/jssc.200900687
35. He Z. Q., Findlay J. A., Constituents of Astragalus membranaceus. Journal of Natural Products 1991 54 3 810 815 2-s2.0-0025984866
36. Xu Q., Ma X. Q., Liang X. M., Determination of astragalosides in the roots of Astragalus spp. using liquid chromatography tandem atmospheric pressure chemical ionization mass spectrometry. Phytochemical Analysis 2007 18 5 419 427 2-s2.0-34548787353 10.1002/pca.997 (Pubitemid 47422798)
37. Lee E. J., Yean M. H., Jung H. S., Kim J. S., Kang S. S., Phytochemical studies on Astragalus root (2)-flavonoids and a lignan. Natural Product Sciences 2008 14 2 131 137 2-s2.0-46949107871 (Pubitemid 351962138)
38. Zhang L. J., Liu H. K., Hsiao P. C., Kuo L. Y., Lee I., Wu T., Chiou W., Kuo Y., New isoflavonoid glycosides and related constituents from astragali radix (Astragalus membranaceus) and their inhibitory activity on nitric oxide production. Journal of Agricultural and Food Chemistry 2011 59 4 1131 1137 2-s2.0-79951764536 10.1021/jf103610j
39. Lin L. Z., He X. G., Lindenmaier M., Nolan G., Yang J., Cleary M., Qiu S., Cordell G. A., Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus. Journal of Chromatography A 2000 876 1-2 87 95 2-s2.0-0034697372 10.1016/S0021-9673(00)00149-7 (Pubitemid 30211552)
40. Wu X. Y., Chen W., Yu M. H., Effect of astragalus polysaccharides on expression of IL-4 and IFN- γ in non-obese diabetic mice. Chinese Journal of Rehabilitation Theory and Practice 2008 14 2 147 149
41. Chen W., Liu F., Yu M., Zhu Q., Zhu X., Astragalus polysaccharide prevent type 1 diabetes in nonobese diabetic mice. Fudan University Journal of Medical Sciences 2001 28 1 57 60 2-s2.0-0042817967
42. Chen W., Li Y.-M., Yu M.-H., Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice. Experimental and Clinical Endocrinology and Diabetes 2008 116 8 468 474 2-s2.0-54549118063 10.1055/s-2008-1058081
43. Chen W., Xia Y. P., Yu M. H., Shi X. M., Astragalus polysaccharides effect on pancreatic histopathology. China Journal of Modern Medicine 2007 17 2 146 148
44. Li R. J., Qiu S. D., Chen H. X., Tian H., Wang H. X., The immunotherapeutic effects of Astragalus polysaccharide in type 1 diabetic mice. Biological and Pharmaceutical Bulletin 2007 30 3 470 476 2-s2.0-33847688982 10.1248/bpb.30.470 (Pubitemid 46355927)
45. Li R. J., Qiu S. D., Chen H. X., Tian H., Liu G., Effect of Astragalus polysaccharide on pancreatic cell mass in type 1 diabetic mice. Zhongguo Zhongyao Zazhi 2007 32 20 2169 2173 2-s2.0-36948998583
46. Chen W., Li Y. M., Yu M. H., Shi X. M., Immunoloregulation effects of Astragalus Polysaccharides on T helper lymphocyte subgroups in nonobese diabetic Mice. China Journal of Modern Medicine 2007 17 1 28 35
47. Wong F. S., Siew L. K., Scott G., Thomas I. J., Chapman S., Viret C., Wen L., Activation of insulin-reactive cd8 t-cells for development of autoimmune diabetes. Diabetes 2009 58 5 1156 1164 2-s2.0-65549086920 10.2337/db08-0800
48. Harty J. T., Tvinnereim A. R., White D. W., Cd8+ T cell effector mechanisms in resistance to infection. Annual Review of Immunology 2000 18 275 308 2-s2.0-0034097041 10.1146/annurev.immunol.18.1.275 (Pubitemid 30365382)
49. Dong C., Flavell R. A., Cell fate decision: T-helper 1 and subsets in immune responses. Arthritis Research 2000 2 3 179 188 2-s2.0-0034469924 10.1186/ar85 (Pubitemid 32223725)
50. Crane I. J., Forrester J. V., Th1 and Th2 lymphocytes in autoimmune disease. Critical Reviews in Immunology 2005 25 2 75 102 2-s2.0-21344467014 10.1615/CritRevImmunol.v25.i2.10 (Pubitemid 40910583)
51. Chen W., Yu M. H., Effects of Astragalus polysaccharide on gene expression profiles in islets of NOD mice with microarray technique Chinese. Chinese Journal of Endocrinology and Metabolism 2004 20 6 545 548
52. Chen W., Li Y. M., Yu M. H., Astragalus polysaccharides influence ultrastructure of islets and Th1/Th2 cvtokine gene expression of pancrease in NOD mice. Chinese Journal of Endocrinology and Metabolism 2007 23 3 269 271
53. Li R. J., Qiu S. D., Chen H. X., Wang L. R., Immunomodulatory effects of Astragalus polysaccharide in diabetic mice. Zhong Xi Yi Jie He Xue Bao 2008 6 2 166 170
54. Azar S. T., Tamim H., Beyhum H. N., Zouhair Habbal M., Almawi W. Y., Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease. Clinical and Diagnostic Laboratory Immunology 1999 6 3 306 310 2-s2.0-0032964001 (Pubitemid 29226796)
55. Chen W., Yu M. H., Li Y. M., Effects of astragalus polysaccharides on ultrastructure and oxidation/ apoptosis related cytokines' gene expression of non-obese diabetic mice's islets. Fudan University Journal of Medical Sciences 2007 34 2 269 272 2-s2.0-36949007954
56. Guri A. J., Mohapatra S. K., Horne W. T. II, Hontecillas R., Bassaganya-Riera J., The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease. BMC Gastroenterology 2010 10 10 60 2-s2.0-77953248869 10.1186/1471-230X-10-60
57. Soromou L. W., Chen N., Jiang L., Huo M., Wei M., Chu X., Millimouno F. M., Feng H., Sidime Y., Deng X., Astragalin attenuates lipopolysaccharide- induced inflammatory responses by down-regulating NF- B signaling pathway. Biochemical and Biophysical Research Communications 2012 419 2 256 261 2-s2.0-84858000366 10.1016/j.bbrc.2012.02.005
58. Kim M. S., Kim S. H., Inhibitory effect of astragalin on expression of lipopolysaccharideinduced inflammatory mediators through NF- B in macrophages. Archives of Pharmacal Research 2011 34 12 2101 2107 2-s2.0-84857157288 10.1007/s12272-011-1213-x
59. Mao S. M., Li C. D., Wang L., Wang J., Dai G., Kang B., Effect and mechanism of astragalus polysaccharides on apoptosis of the islet beta cell in diabetes mellitus rats. Chinese Pharmacological Bulletin 2009 25 9 1227 1229 2-s2.0-72149085169
60. Zhou X. J., Xu Y. C., Yang G. M., Li F., Increased galectin-1 expression in muscle of Astragalus polysaccharide-treated Type 1 diabetic mice. Journal of Natural Medicines 2011 65 3-4 500 507 2-s2.0-79960445859 10.1007/s11418-011- 0527-9
61. Li C. D., Li J. J., Wang L., Wang J. H., Dai G., Kang B., Mao S. M., Inhibitory effect of astragalus polysaccharides on apoptosis of pancreatic beta-cells mediated by Fas in diabetes mellitus rats. Zhong Yao Cai 2011 34 10 1579 1582
62. Mao S. M., Li C. D., Wang L., Han H. R., Wang J. H., Dai G., Kang B., Effects of astragalus polysaccharides on the ultrastructure and Fas expression of pancreatic beta-cells in diabetes mellitus rats. Chinese Pharmacological Bulletin 2010 26 6 791 793 2-s2.0-77956815796
63. Wang Y., Zhu Y., Gao L., Yin H., Xie Z., Wang D., Zhu Z., Han X., Formononetin attenuates IL-1 β -induced apoptosis and NF- B activation in INS-1 cells. Molecules 2012 17 9 10052 10064
64. Liu M., Wu K., Mao X., Wu Y., Ouyang J., Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle. Journal of Ethnopharmacology 2010 127 1 32 37 2-s2.0-72149094306 10.1016/j.jep.2009.09.055
65. Zou F., Mao X. Q., Wang N., Liu J., Ou-Yang J. P., Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK. Acta Pharmacologica Sinica 2009 30 12 1607 1615 2-s2.0-74949118250 10.1038/aps.2009.168
66. Liao W. P., Shi Y. G., Effect of astragalus polysaccharides and soy isoflavones on glucose metabolism in diabetic rats. Acta Academiae Medicinae Militaris Tertiae 2007 29 5 416 418
67. Wang N., Zhang D., Mao X., Zou F., Jin H., Ouyang J., Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes. Molecular and Cellular Endocrinology 2009 307 1-2 89 98 2-s2.0-67349167991 10.1016/j.mce.2009.03.001
68. Liu H. F., Ren Y. H., Han Z. X., Effect of astragalus poly saccharides on insulin resistance and gene expression of GLUT4 in type 2 diabetes mellitus rats. Chinese Journal of Gerontology 2011 31 20 3988 3989
69. Kelley D. E., Goodpaster B. H., Skeletal muscle triglyceride: an aspect of regional adiposity and insulin resistance. Diabetes Care 2001 24 5 933 941 2-s2.0-0035345532 (Pubitemid 33636072)
70. Li N., Fan Y., Jia X. M., Ma Z., Lin S. R., Effect of astragali radix active ingredients on serum insulin and adiponectin in diabetes rats. Chinese Journal of Experimental Traditional Medical Formulae 2011 17 5 144 146
71. Li N., Fan Y., Jia X. M., Lin S. R., Ma Z., Effect of Astragalus active ingredients on AdipoR1 and AMPK mRNA expression in diabetic rats. China Journal of Traditional Chinese Medicine and Pharmacy 2011 26 5 1176 1181
72. Wu D. H., Wang F. J., Deng J., Effect of APS on the expression of phosphyorylation of AMPK in liver tissue of type 2 diabetic rat. Chinese Journal of Microcirculation 2009 19 3 1 3
73. Spranger J., Kroke A., Möhlig M., Bergmann M. M., Ristow M., Boeing H., Pfeiffer A. F. H., Adiponectin and protection against type 2 diabetes mellitus. The Lancet 2003 361 9353 226 228 2-s2.0-0037452139 10.1016/S0140-6736(03)12255-6 (Pubitemid 36126226)
74. Lele R. D., Pro-insulin, C peptide, glucagon, adiponectin, TNF α AMPK: neglected players in type 2 diabetes mellitus. Journal of Association of Physicians of India 2010 58 30 35 40 2-s2.0-73249118523
75. Koh E. H., Kim M., Park J., Kim H. S., Youn J., Park H., Youn J. H., Lee K., Peroxisome proliferator-activated receptor (PPAR)- α activation prevents diabetes in OLETF rats: comparison with PPAR- γ activation. Diabetes 2003 52 9 2331 2337 2-s2.0-0042822095 10.2337/diabetes.52.9.2331 (Pubitemid 37059504)
76. Wei C., Yanping X., Xuelan Z., Hao W., Wenjie C., Maohua Y., Yiming L., Hongying Y., Yu Z., The critical role of Astragalus polysaccharides for the improvement of PPRA α -mediated lipotoxicity in diabetic cardiomyopathy. PLOS One 2012 7 10 1 10 e45541
77. 2 expression in streptozotocin-induced diabetic rats. Journal of Liaoning University of Traditional Chinese Medicine 2011 13 1 48 49
78. Narayanan S., Aldose reductase and its inhibition in the control of diabetic complications. Annals of Clinical and Laboratory Science 1993 23 2 148 158 2-s2.0-0027400468 (Pubitemid 23093793)
79. Yang H. Z., Zhou M. M., Zhao A. H., Xing S. N., Fan Z. Q., Jia W., Study on effects of baicalin, berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro. Zhong Yao Cai 2009 32 8 1259 1261 2-s2.0-77957305003
80. Xu A., Wang H., Hoo R. L. C., Sweeney G., Vanhoutte P. M., Wang Y., Wu D., Chu W., Qin G., Lam K. S. L., Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 2009 150 2 625 633 2-s2.0-59649117072 10.1210/en.2008-0999
81. Yu J., Zhang Y., Sun S., Shen J., Qiu J., Yin X., Yin H., Jiang S., Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Canadian Journal of Physiology and Pharmacology 2006 84 6 579 587 2-s2.0-33750215522 10.1139/Y06-015 (Pubitemid 44605721)
82. Wang N., Mao X. Q., Wang S., Zhang C., Zou F., Ouyang J. P., Effects of APS on reducing ER stress and increasing insulin sensitivity in a rat model of type 2 diabetes. Journal of Public Health and Preventive Medicine 2007 18 4 13 16
83. Mao X. Q., Wu Y., Wu K., Liu M., Zhang J. F., Zou F., Ou-Yang J., Astragalus polysaccharide reduces hepatic endoplasmic reticulum stress and restores glucose homeostasis in a diabetic KKAy mouse model. Acta Pharmacologica Sinica 2007 28 12 1947 1956 2-s2.0-36649011202 10.1111/j.1745-7254.2007.00674.x (Pubitemid 350198342)
84. Wu Y., Ou-Yang J. P., Wu K., Wang Y., Zhou Y., Wen C., Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacologica Sinica 2005 26 3 345 352 2-s2.0-15244348325 10.1111/j.1745-7254.2005.00062.x (Pubitemid 40388072)
85. Mao X., Yu F., Wang N., Wu Y., Zou F., Wu K., Liu M., Ouyang J., Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism. Phytomedicine 2009 16 5 416 425 2-s2.0-64449084587 10.1016/j.phymed.2008.12.011
86. Kovacs P., Hanson R. L., Lee Y., Yang X., Kobes S., Permana P. A., Bogardus C., Baier L. J., The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians. Diabetes 2003 52 12 3005 3009 2-s2.0-0344412860 10.2337/diabetes.52.12.3005 (Pubitemid 37466873)
87. Zeggini E., Parkinson J., Halford S., Owen K. R., Frayling T. M., Walker M., Hitman G. A., Levy J. C., Sampson M. J., Feskens E. J. M., Hattersley A. T., McCarthy M. I., Association studies of insulin receptor substrate 1 gene (IRS1) variants in type 2 diabetes samples enriched for family history and early age of onset. Diabetes 2004 53 12 3319 3322 2-s2.0-9444276572 10.2337/diabetes.53. 12.3319 (Pubitemid 39564510)
88. Liu H. F., Zhang Y., Hu Z., Effect of Astragalus polysaccharides on gene expression of resistin in type 2 diabetes mellitus rats. Journal of Mudanjiang Medical University 2011 32 4 9 10
89. Liu H. F., Chen H. J., Wang G. Y., Han Z. X., Zhang J., Effect of astragalus polysaccharides on insulin resistance and protein pxpression of resistin in type 2 diabetes mellitus rats. Food and Nutrition in China 2012 18 1 69 71
90. Lawlor M. A., Alessi D. R., PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? Journal of Cell Science 2001 114 16 2903 2910 2-s2.0-0034845958 (Pubitemid 32821530)
91. Karlsson H. K. R., Zierath J. R., Kane S., Krook A., Lienhard G. E., Wallberg-Henriksson H., Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 2005 54 6 1692 1697 2-s2.0-20044389885 10.2337/diabetes.54.6.1692 (Pubitemid 40770759)
92. Özcan U., Cao Q., Yilmaz E., Lee A., Iwakoshi N. N., Özdelen E., Tuncman G., Görgün C., Glimcher L. H., Hotamisligil G. S., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004 306 5695 457 461 2-s2.0-5644231992 10.1126/science.1103160 (Pubitemid 39372439)
93. Fu Z., Gilbert E. R., Liu D. M., Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Current Diabetes Reviews 2013 9 1 25 53
94. Reginato M. J., Lazar M. A., Mechanisms by which thiazolidinediones enhance insulin action. Trends in Endocrinology and Metabolism 1999 10 1 9 13 2-s2.0-0033039662 10.1016/S1043-2760(98)00110-6 (Pubitemid 29288704)